AVERSION® Technology

AVERSION® Technology is a patented composition of commonly used active and inactive pharmaceutical ingredients providing abuse deterrent features and benefits for orally administered pharmaceutical drug products. AVERSION® Technology opioid analgesic product candidates are intended to provide effective relief from pain while discouraging common methods of pharmaceutical product misuse and abuse including:

  • Intravenous injection by forming a viscous gelatinous mixture when tablets and capsules are dissolved in solvents suitable for injection; and More
  • Nasal snorting by inducing disliked nasal discomfort when tablets and capsules are crushed and snorted. More